Tiedemann Advisors’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$349K	Hold	5,032	–	–	0.01%	205
2023 Q2	$475K	Buy	5,032 +238	+5%	+$20.7K	0.02%	162
2023 Q1	$397K	Hold	4,794	–	–	0.02%	174
2022 Q4	$358K	Hold	4,794	–	–	0.02%	181
2022 Q3	$396K	Hold	4,794	–	–	0.02%	162
2022 Q2	$456K	Sell	4,794 -277	-5%	-$28.7K	0.03%	160
2022 Q1	$596K	Buy	5,071 +172	+4%	+$19.3K	0.03%	176
2021 Q4	$635K	Sell	4,899 -5	-0.1%	-$583	0.03%	170
2021 Q3	$556K	Sell	4,904 -2,262	-32%	-$258K	0.03%	183
2021 Q2	$742K	Buy	7,166 +1,876	+35%	+$177K	0.03%	194
2021 Q1	$442K	Buy	5,290 +210	+4%	+$17.8K	0.02%	223
2020 Q4	$463K	Buy	5,080 +43	+0.9%	+$3.57K	0.02%	209
2020 Q3	$402K	Sell	5,037 -462	-8%	-$36K	0.02%	240
2020 Q2	$380K	Sell	5,499 -12	-0.2%	-$853	0.02%	229
2020 Q1	$346K	Buy	5,511 +927	+20%	+$66.9K	0.02%	223
2019 Q4	$357K	Sell	4,584 -1,482	-24%	-$116K	0.02%	232
2019 Q3	$444K	Buy	6,066 +1,968	+48%	+$138K	0.02%	228
2019 Q2	$252K	Sell	4,098 -24,720	-86%	-$1.49M	0.01%	254
2019 Q1	$1.84M	Buy	28,818 +14,532	+102%	+$829K	0.09%	144
2018 Q4	$729K	Buy	14,286 +10,206	+250%	+$516K	0.04%	242
2018 Q3	$237K	Sell	4,080 -585	-13%	-$28.6K	0.01%	280
2018 Q2	$226K	Sell	4,665 -6,339	-58%	-$296K	0.01%	279
2018 Q1	$512K	Buy	+11,004	New	+$478K	0.04%	197
2017 Q3	–	Sell	-107,397	Closed	-$4.23M	–	380
2017 Q2	$4.23M	Buy	107,397 +34,491	+47%	+$1.26M	0.31%	63
2017 Q1	$2.29M	Buy	+72,906	New	+$2.28M	0.19%	107